Filing Details
- Accession Number:
- 0001179110-17-008141
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-26 16:50:17
- Reporting Period:
- 2017-05-24
- Filing Date:
- 2017-05-26
- Accepted Time:
- 2017-05-26 16:50:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
856982 | Merit Medical Systems Inc | MMSI | Surgical & Medical Instruments & Apparatus (3841) | 870447695 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1184931 | W Richard Edelman | 1600 W. Merit Parkway South Jordan UT 84095 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, No Par Value | Acquisiton | 2017-05-24 | 11,621 | $13.16 | 17,621 | No | 4 | M | Direct | |
Common Stock, No Par Value | Disposition | 2017-05-24 | 7,437 | $34.50 | 10,184 | No | 4 | S | Direct | |
Common Stock, No Par Value | Acquisiton | 2017-05-25 | 13,379 | $13.16 | 23,563 | No | 4 | M | Direct | |
Common Stock, No Par Value | Disposition | 2017-05-25 | 8,563 | $34.42 | 15,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified stock options (right to buy) | Disposition | 2017-05-24 | 11,621 | $0.00 | 11,621 | $13.16 |
Common Stock | Non-qualified stock options (right to buy) | Disposition | 2017-05-25 | 13,379 | $0.00 | 13,379 | $13.16 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
13,379 | 2011-06-25 | 2017-06-25 | No | 4 | M | Direct |
0 | 2011-06-25 | 2017-06-25 | No | 4 | M | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified stock options (right to buy) | $13.75 | 2012-08-11 | 2018-08-11 | 20,000 | 20,000 | Direct |
Common Stock | Non-qualified stock options (right to buy) | $12.91 | 2013-05-23 | 2019-05-23 | 20,000 | 20,000 | Direct |
Common Stock | Non-qualified stock options (right to buy) | $9.95 | 2014-05-22 | 2020-05-22 | 25,000 | 25,000 | Direct |
Common Stock | Non-qualified stock options (right to buy) | $13.99 | 2015-06-11 | 2021-06-11 | 25,000 | 25,000 | Direct |
Common Stock | Non-qualified stock options (right to buy) | $20.27 | 2016-05-22 | 2022-05-22 | 25,000 | 25,000 | Direct |
Common Stock | Non-qualified stock options (right to buy) | $18.80 | 2017-05-26 | 2023-05-26 | 25,000 | 25,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2018-08-11 | 20,000 | 20,000 | Direct |
2019-05-23 | 20,000 | 20,000 | Direct |
2020-05-22 | 25,000 | 25,000 | Direct |
2021-06-11 | 25,000 | 25,000 | Direct |
2022-05-22 | 25,000 | 25,000 | Direct |
2023-05-26 | 25,000 | 25,000 | Direct |
Footnotes
- The Reporting Person ceased to be a director of the Issuer on March 24, 2017.
- The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 7,437 of such shares to pay the exercise price and taxes and issuing the remaining 4,184 shares to the Reporting Person.
- The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 8,563 of such shares to pay the exercise price and taxes and issuing the remaining 4,816 shares to the Reporting Person.
- The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.40 to 34.50, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- Became exercisable in equal annual installments of 20% commencing 06/25/2011.
- Became exercisable in equal annual installments of 20% commencing 08/11/2012.
- Became exercisable in equal annual installments of 20% commencing 05/23/2013.
- Became exercisable in equal annual installments of 20% commencing 05/22/2014. Installments scheduled for vesting after 5/22/2017 will not be exercisable.
- Became exercisable in equal annual installments of 20% commencing 06/11/2015. Installments scheduled for vesting after 6/11/2017 will not be exercisable.
- Became exercisable in equal annual installments of 20% commencing 05/22/2016. Installments scheduled for vesting after 5/22/2017 will not be exercisable.
- Became exercisable in equal annual installments of 20% commencing 05/26/2017. Installments scheduled for vesting after 5/26/2017 will not be exercisable.